Agile Therapeutics (AGRX) Announces Delisting
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St futures kick off September under pressure as yields, oil prices rise
- Oil up around 2% as renewed US-Iran strikes stoke supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
Agile Therapeutics Announces Delisting from Nasdaq
March 25, 2024 4:30 PM EDTPRINCETON, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (Agile Therapeutics or the Company), a women's healthcare company, today announced that the Company has received a final delisting notice from Nasdaq.
The delisting is a result of failure to regain compliance with the minimum stockholders equity requirement for continued listing on the Nasdaq Capital Market set forth in Nasdaq Listing Rule 5550(b)(1) requiring companies listed on the Nasdaq Capital Market to maintain stockholders equity of at least $2,500,000. Suspension of trading in the Companys common stock on the... More
